/
Eur J Cancer
Treatment with ribociclib shows favourable immunomodulatory effects in patients with hormone receptor-positive breast cancer-findings from the RIBECCA trial
- C.A. Peuker
- S. Yaghobramzi
- C. Grunert
- L Keilholz
- E. Gjerga
- S. Hennig
- S. Schaper
- I.K. Na
- U. Keller
- S. Brucker
- T. Decker
- P. Fasching
- T. Fehm
- W. Janni
- S. Kümmel
- A. Schneeweiss
- M. Schuler
- D. Lüftner
- A. Busse